TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,833,198 | -67.6% | 2,850,861 | -3.8% | 0.01% | -66.7% |
| Q2 2023 | $73,645,259 | +98.9% | 2,964,785 | +20.5% | 0.02% | +87.5% |
| Q1 2023 | $37,017,170 | +13.7% | 2,461,248 | -10.6% | 0.01% | -11.1% |
| Q4 2022 | $32,552,232 | +203.7% | 2,751,668 | +52.0% | 0.01% | +125.0% |
| Q3 2022 | $10,718,000 | +63.2% | 1,810,472 | +17.2% | 0.00% | +300.0% |
| Q2 2022 | $6,567,000 | -58.9% | 1,545,185 | -8.0% | 0.00% | -66.7% |
| Q1 2022 | $15,976,000 | -74.1% | 1,679,929 | -48.3% | 0.00% | +200.0% |
| Q4 2021 | $61,694,000 | -8.8% | 3,246,902 | +59.8% | 0.00% | -87.5% |
| Q3 2021 | $67,628,000 | +1.7% | 2,032,081 | +18.5% | 0.01% | -11.1% |
| Q2 2021 | $66,512,000 | -1.8% | 1,714,676 | +22.0% | 0.01% | -18.2% |
| Q1 2021 | $67,732,000 | -51.6% | 1,405,234 | -47.8% | 0.01% | 0.0% |
| Q4 2020 | $140,060,000 | +315.8% | 2,692,452 | +113.9% | 0.01% | +83.3% |
| Q3 2020 | $33,681,000 | +90.2% | 1,258,632 | +38.4% | 0.01% | +50.0% |
| Q2 2020 | $17,711,000 | +28.4% | 909,158 | -35.1% | 0.00% | -20.0% |
| Q1 2020 | $13,790,000 | +27.0% | 1,401,394 | +43.2% | 0.01% | +66.7% |
| Q4 2019 | $10,860,000 | +162.1% | 978,400 | +32.6% | 0.00% | +200.0% |
| Q3 2019 | $4,144,000 | -83.2% | 737,845 | -74.1% | 0.00% | -66.7% |
| Q2 2019 | $24,674,000 | +121.2% | 2,852,257 | +105.6% | 0.00% | -40.0% |
| Q1 2019 | $11,155,000 | +735.0% | 1,387,403 | +325.8% | 0.01% | – |
| Q4 2018 | $1,336,000 | -59.9% | 325,872 | -45.3% | 0.00% | -100.0% |
| Q3 2018 | $3,333,000 | -77.2% | 595,300 | -46.5% | 0.00% | -80.0% |
| Q2 2018 | $14,621,000 | -3.7% | 1,111,894 | +4.0% | 0.01% | -16.7% |
| Q1 2018 | $15,177,000 | +96.7% | 1,068,731 | +13.6% | 0.01% | +100.0% |
| Q4 2017 | $7,714,000 | -11.0% | 940,756 | +28.5% | 0.00% | -25.0% |
| Q3 2017 | $8,672,000 | +60.1% | 731,878 | +35.8% | 0.00% | +100.0% |
| Q2 2017 | $5,417,000 | +19.2% | 539,082 | +38.2% | 0.00% | 0.0% |
| Q1 2017 | $4,546,000 | +604.8% | 390,204 | +181.2% | 0.00% | – |
| Q4 2016 | $645,000 | +83.2% | 138,747 | +204.7% | 0.00% | – |
| Q3 2016 | $352,000 | -11.3% | 45,531 | -30.5% | 0.00% | – |
| Q2 2016 | $397,000 | -78.9% | 65,523 | -70.3% | 0.00% | -100.0% |
| Q1 2016 | $1,879,000 | -31.0% | 220,511 | -3.5% | 0.00% | 0.0% |
| Q4 2015 | $2,724,000 | +11.1% | 228,405 | -6.1% | 0.00% | 0.0% |
| Q3 2015 | $2,451,000 | -64.1% | 243,146 | -40.9% | 0.00% | -66.7% |
| Q2 2015 | $6,826,000 | +27.1% | 411,521 | +18.6% | 0.00% | 0.0% |
| Q1 2015 | $5,372,000 | +81.2% | 346,996 | +85.4% | 0.00% | +200.0% |
| Q4 2014 | $2,965,000 | -13.8% | 187,159 | -41.9% | 0.00% | 0.0% |
| Q3 2014 | $3,439,000 | +39.7% | 322,244 | +22.9% | 0.00% | 0.0% |
| Q2 2014 | $2,462,000 | +504.9% | 262,109 | +344.7% | 0.00% | – |
| Q1 2014 | $407,000 | +236.4% | 58,942 | +90.5% | 0.00% | – |
| Q4 2013 | $121,000 | +53.2% | 30,945 | +149.4% | 0.00% | – |
| Q2 2013 | $79,000 | – | 12,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,434,783 | $60,326,000 | 5.25% |
| RA Capital Management | 9,880,323 | $109,672,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,907,492 | $21,173,000 | 1.53% |
| Eversept Partners, LP | 776,323 | $8,617,185 | 1.52% |
| Opaleye Management Inc. | 579,651 | $6,434,000 | 1.26% |
| Sofinnova Investments, Inc. | 811,292 | $9,006,000 | 0.65% |
| Ikarian Capital, LLC | 316,200 | $3,510,000 | 0.57% |
| ARMISTICE CAPITAL, LLC | 800,000 | $8,880,000 | 0.51% |
| 683 Capital Management, LLC | 398,271 | $4,421,000 | 0.51% |
| Frontier Wealth Management LLC | 196,750 | $2,184,000 | 0.35% |